Nov 21, 2024
To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - HDFC Pharma and Healthcare Fund - Regular (G) | -1.36 | 24.89 | 49.76 | 0 |
| Benchmark - S&P BSE Healthcare TRI | -1.88 | 10.85 | 37 | 11.94 |
| Category Average - BEST EQUITY PERFORMERS | -5.68 | 5.42 | 28.95 | 16.31 |
| Category Rank | 8/7 | 7/7 | 7/7 | 7/7 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund (G) | 412.0900 | 0.83 | 43.61 | 22.95 | 28.63 | 3,416.13 | 1.95 | 5,000.00 | invest |
| SBI Healthcare Opportunities Fund (IDCW) | 259.5954 | 0.83 | 43.61 | 22.95 | 28.64 | 3,416.13 | 1.95 | 5,000.00 | invest |
| AXIS Innovation Fund (G) | 17.9100 | 0.79 | 30.92 | 9.00 | 0.00 | 1,225.58 | 2.21 | 100.00 | invest |
| AXIS Innovation Fund (IDCW) | 17.9100 | 0.79 | 30.92 | 9.00 | 0.00 | 1,225.58 | 2.21 | 100.00 | invest |
| Tata Quant Fund - Regular (IDCW) | 14.7462 | -2.52 | 16.16 | 11.33 | 0.00 | 67.78 | 0.00 | 5,000.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Oct 31, 2024 | 193.79 | 14.02 | 28.64 |
|
| Equity-Cipla | Oct 31, 2024 | 112.91 | 8.17 | 58.15 |
|
| Equity-Divi`s Lab. | Oct 31, 2024 | 109.31 | 7.91 | 14.20 |
|
| Equity-Lupin | Oct 31, 2024 | 86.44 | 6.25 | 24.63 |
|
| Equity-Ipca Labs. | Oct 31, 2024 | 56.35 | 4.08 | 6.05 |
|
| Equity-Gland Pharma | Oct 31, 2024 | 55.35 | 4.00 | 29.03 |
|
| Equity-Aurobindo Pharma | Oct 31, 2024 | 47.58 | 3.44 | -4.39 |
|
| Equity-Piramal Pharma | Oct 31, 2024 | 47.11 | 3.41 | 17.23 |
|
| Equity-Dr Reddy`s Labs | Oct 31, 2024 | 45.87 | 3.32 | -5.64 |
|
| Equity-ERIS Lifescience | Oct 31, 2024 | 45.28 | 3.27 | 9.17 |
|
HDFC Mutual Fund has announced 25 November 2024 as the record date for decl...
HDFC Mutual Fund has announced 21 November 2024 as the record date for decl...
HDFC Mutual Fund has announced 21 November 2024 as the record date for decl...
HDFC Mutual Fund has announced change in scheme name under the following sc...
HDFC Mutual Fund has announced 25 October 2024 as the record date for decla...
HDFC Mutual Fund has announced 24 October 2024 as the record date for decla...
| AMC Name | : | HDFC Mutual Fund |
| Fund Name | : | HDFC Pharma and Healthcare Fund - Regular (G) |
| Contact Persone | : | Nikhil Mathur |
| Registered Address | : | HDFC House, 2nd Flr, H.T.Parekh Marg,165-166, Backbay Reclamation,Churchgate, Mumbai - 400 020. |
| Telephone No | : | 022 - 6631 6333 |
| Fax No. | : | 022 - 22821144 |
| : | hello@hdfcfund.com | |
| Website | : | www.hdfcfund.com |
Top Mutual Funds
